UNSPSC 51162016: Calcium iodide/isoproterenol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162016 Calcium iodide/isoproterenol is a Commodity code with minimal direct alignment to recent state and local opportunities. The code's nominal scope — pharmaceutical ingredients for asthma and shock treatment — does not match the work actually being solicited under this code designation in the recent-opportunities block. Seminole County, Florida and Hall County, Georgia have posted opportunities tagged to this code, but the actual procurements are for naloxone and safe drug deactivation systems (Seminole County), and comprehensive on-site pharmacy services including formulary stocking and dispensing across multiple therapeutic categories (Hall County). Neither opportunity involves calcium iodide or isoproterenol products. The mismatch suggests either coding error in the tagging or a legacy classification issue; the code shows little relevant recent activity in state and local procurement.

Seminole County (Florida) solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through IFB 60459723LAS with a response deadline of July 26, 2023, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford with an initial two-year contract term and one-year renewal option. Hall County (Georgia) issued RFQ/P #47-010 on May 4, 2026, to procure on-site pharmacy services for approximately 3,005 eligible individuals in the county's group health insurance plans, with sealed proposals due June 4, 2026, using an 80/20 scoring structure (80% technical qualifications, 20% cost) and an initial one-year term beginning January 1, 2027, with four additional one-year renewal options. Both opportunities reflect state and county health and safety procurement activity in the Southeast, though neither directly involves the pharmaceutical ingredients named in the code.